20th Jan 2025 08:40
(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or recurrent endometrial cancer eligible for systemic therapy. Read More